Back to Dashboard

IM048-022 (EXCALIBER-Maint))

MM•IM048-022 (EXCALIBER-Maint))•Last updated: 2/25/2026

Recruiting

Study Design

Study Drug

Iberdomide

Mechanism of Action

CUL4-CRBN E3-Bite

Sponsor

Unknown

Design

III

Control Arm

Lenalidomide

Criteria

Inclusion Criteria

after ASCT with NDMM

Age: Phase: III

Exclusion Criteria

Enrollment

Progress2 / 7

Contact Information

Principal Investigator

陳彩雲

Study Nurse

曾睦捷

Contact Tel

4620